Skip to main content

Comparison guide

Zepbound alternative Compare with clarity.

Zepbound is an FDA-approved tirzepatide product. REMEVi offers compounded tirzepatide when prescribed, not Zepbound or a generic version of it. The decision involves product approval, medical suitability, the full cost at your prescribed dose and ongoing support.

Published by REMEVi · Editorial update:

Which products you are comparing

Zepbound has an approved indication for chronic weight management in patients meeting its labeling criteria. Evaluation includes medical history, other medicines and tolerability; wanting to lose weight is not enough. Zepbound prescribing information ↗

REMEVi offers compounded tirzepatide when appropriate and prescribed. A compounded preparation does not undergo the same FDA premarket review of safety, effectiveness and quality. It is not Zepbound or an approved generic; sharing an ingredient does not establish clinical equivalence. FDA ↗

FDA recommends considering a compounded preparation only when an approved medicine cannot meet a patient’s medical needs. A lower price, prescription or different dose does not by itself establish that the conditions for compounding a copy of an available medicine are met. FDA post-shortage requirements ↗

Compare the full cost

ItemZepboundREMEVi
ProductFDA-approved medicineCompounded preparation, not FDA-approved
CostDepends on presentation, coverage and savings eligibilityFrom $225 per 4 weeks with the 24-week plan: $1,350 paid upfront. Or $269 every 4 weeks without a long-term prepayment.
Care and follow-upConfirm your prescriber’s charges and included careClinical evaluation and bilingual coordination; confirm your plan’s follow-up
AvailabilityConfirm with your pharmacySubject to evaluation, prescription and pharmacy availability

Four weeks is not a calendar month. Compare the same period, full upfront charge and renewal or cancellation terms. Insurance or manufacturer savings can make a brand less expensive for some people.

Check manufacturer options ↗ · REMEVi plans and full payments →

When to discuss a change

If treatment is hard to tolerate, does not meet your goals or is difficult to afford, discuss it with your prescriber. Ask about approved options and coverage first. Do not stop, combine or convert doses on your own; a change of product can require different instructions.

Disclose personal or family MTC history, MEN 2, allergies, pancreatitis, gastrointestinal problems, kidney disease, other medicines and pregnancy plans. MTC/MEN 2 and hypersensitivity are among the product contraindications; other conditions need individual assessment and precautions. Prescribing warnings ↗

What REMEVi care includes

  1. Complete the initial quiz and, when appropriate, the medical intake in English or Spanish.
  2. A licensed clinician assesses your history and whether an appropriate option exists. Completing intake does not guarantee a prescription.
  3. If prescribed, confirm the pharmacy, concentration, instructions, shipping and follow-up before using the medicine.

Meet the team · Pharmacy information

Frequently asked questions

What should I know before starting?

Confirm which product is prescribed, why it is appropriate for you and how to use it. Discuss your health history, other medicines and pregnancy plans, and agree on follow-up with your clinician.

Is a brand product the same as a compounded preparation?

Compounded preparations are not FDA-approved or established as equivalent to brand products. FDA recommends considering them only when an approved medicine cannot meet a patient’s medical needs. Evaluation and prescribing are individual.

When will I see results?

There is no guaranteed date or amount of weight loss. Response depends on the product, tolerated dose and other factors. Trials assess averages over many months; they do not predict your individual result.

Which side effects need attention?

Nausea, vomiting, diarrhea or constipation can occur, particularly during dose increases. Severity and duration vary. Seek medical care for severe persistent abdominal pain, inability to keep fluids down or symptoms of a serious allergic reaction. Do not change your dose on your own.

How should I compare costs?

REMEVi semaglutide: From $159 per 4 weeks with the 24-week plan: $954 paid upfront. Or $199 every 4 weeks without a long-term prepayment. REMEVi tirzepatide: From $225 per 4 weeks with the 24-week plan: $1,350 paid upfront. Or $269 every 4 weeks without a long-term prepayment. Four weeks is not a calendar month. Brand products may have different costs depending on insurance, presentation and savings eligibility.

From $159/4 weeks 24-week plan · your price never goes up
See if you qualify